Erythropoietic agents in routine clinical practice: a retrospective observational survey of epoetin alfa, epoetin beta and darbepoetin alfa use in anaemia patients with cancer

被引：0
|
作者：
Pujade-Lauraine, Eric [1 ]
Richard, Alain J. [2 ]
Sapede, Claudine [3 ]
机构：
[1] CHU, Hotel Dieu, Serv Oncol, Paris, France
[2] GECEM SA, Paris, France
[3] F Hoffmann La Roche & Cie AG, PBSE, Basel, Switzerland
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：220 / 220
页数：1
相关论文
共 50 条
  • [41] Dutch observational study on anaemia management with epoetin alfa in daily oncology practice - interim analysis results on 1000 patients
    Kehrer, D.
    Bosch van den, J.
    Braun, J. J.
    Kerkhofs, L. G. M.
    Brok, R. G. P. M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 183 - 183
  • [42] Dosing intervals and hemoglobin control in patients with chronic kidney disease and anemia treated with epoetin alfa or darbepoetin alfa: A retrospective cohort study
    Nurko, Saul
    Spirko, Rita
    Law, Amy
    Dennis, Vincent W.
    CLINICAL THERAPEUTICS, 2007, 29 (09) : 2010 - 2021
  • [43] Incidence of symptomatic deep venous thrombosis with epoetin alfa or darbepoetin alfa treatment of anemia in patients with ovarian or primary peritoneal cancer
    Westin, Shannon N.
    Skinner, Elizabeth N.
    Funk, Michele Jonsson
    Gehrig, Paola M.
    Van Le, Linda
    GYNECOLOGIC ONCOLOGY, 2007, 105 (02) : 414 - 417
  • [44] Comparison of Pain and Efficacy of Darbepoetin Alfa and Epoetin Beta Pegol Treatment in Patients Receiving Peritoneal Dialysis
    Otsuka, Tomoyuki
    Sakai, Yukinao
    Yui, Shizuka
    Sukegawa, Masami
    Suzuki, Anna
    Mugishima, Koji
    Sumi, Yuichiro
    Otsuka, Yusuke
    Tsuruoka, Shuichi
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2015, 82 (01) : 24 - 29
  • [45] Epoetin beta - A review of its clinical use in the treatment of anaemia in patients with cancer
    Cheer, SM
    Wagstaff, AJ
    DRUGS, 2004, 64 (03) : 323 - 346
  • [46] Effectiveness of darbepoetin alfa vs epoetin alfa in patients with anemia resulting from myelodysplastic syndrome (MDS): results of a retrospective cohort study.
    Patten, JE
    Sullivan, T
    Mun, Y
    Wallace, J
    PHARMACOTHERAPY, 2005, 25 (03): : 468 - 468
  • [47] Resource utilisation and time commitment associated with correction of anaemia in cancer patients using epoetin alfa
    Lynch, Donna-Marie
    Slaven, Tracey
    CLINICAL DRUG INVESTIGATION, 2007, 27 (09) : 661 - 662
  • [48] Resource Utilisation and Time Commitment Associated with Correction of Anaemia in Cancer Patients Using Epoetin Alfa
    Donna-Marie Lynch
    Tracey Slaven
    Clinical Drug Investigation, 2007, 27 : 661 - 662
  • [49] Resource Utilisation and Time Commitment Associated with Correction of Anaemia in Cancer Patients Using Epoetin Alfa
    Kenneth R. Meehan
    N. Simon Tchekmedyian
    Robert E. Smith
    Joel Kallich
    Clinical Drug Investigation, 2006, 26 : 593 - 601
  • [50] Resource utilisation and time commitment associated with correction of anaemia in cancer patients using epoetin alfa
    Meehan, Kenneth R.
    Tchekmedyian, N. Simon
    Smith, Robert E.
    Kallich, Joel
    CLINICAL DRUG INVESTIGATION, 2006, 26 (10) : 593 - 601
12345